Executive at Unicycive (UNCY) granted 169,500 restricted stock units

(Neutral)

Form Type

4/A

Rhea-AI Filing Summary

Gupta Pramod reported acquisition or exercise transactions in this Form 4 filing.

Unicycive Therapeutics, Inc. reported that EVP, Pharmaceuticals and BD, Pramod Gupta received a grant of 169,500 restricted stock units (RSUs) payable solely in common stock. This is a compensation-related award, not an open-market share purchase or sale.

According to the award terms, 23,542 shares vest upon grant, and 4,708 shares vest monthly over 31 months beginning on June 1, 2026, subject to Gupta’s continued service with the company. Following this grant, his reported derivative holdings from this RSU award total 169,500 underlying shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Gupta Pramod

Role EVP, Pharmaceuticals and BD

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	169,500	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 169,500 shares (Direct)

Footnotes (1)

F1. Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. 23,542 shares vest upon grant and 4,708 shares vest monthly over 31 months beginning June 1, 2026, subject to the Reporting Person's continued service with the Issuer.

Key Figures

RSUs granted: 169,500 units Immediate vesting portion: 23,542 shares Monthly vesting amount: 4,708 shares +3 more

6 metrics

RSUs granted 169,500 units Restricted Stock Unit award to EVP on May 14, 2026

Immediate vesting portion 23,542 shares RSUs vesting upon grant under the RSU Award

Monthly vesting amount 4,708 shares Vesting each month over 31 months beginning June 1, 2026

Vesting term 31 months Monthly vesting period starting June 1, 2026

Price per RSU $0.00 per unit Grant of restricted stock units as compensation, not a purchase

Holdings after grant 169,500 underlying shares Total shares covered by RSU Award following the transaction

Key Terms

Restricted Stock Unit, RSU Award, vest, continued service

4 terms

Restricted Stock Unit financial

"Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

RSU Award financial

"Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer."

vest financial

"23,542 shares vest upon grant and 4,708 shares vest monthly over 31 months beginning June 1, 2026, subject to the Reporting Person's continued service with the Issuer."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

continued service financial

"4,708 shares vest monthly over 31 months beginning June 1, 2026, subject to the Reporting Person's continued service with the Issuer."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/15/2026 - 05:24 PM Accepted by SEC EDGAR 06/15/2026 - 05:24 PM

FAQ

What insider transaction did Unicycive Therapeutics (UNCY) report for Pramod Gupta?

Unicycive reported that EVP, Pharmaceuticals and BD, Pramod Gupta received a grant of 169,500 restricted stock units. These RSUs are payable solely in common stock and represent a compensation award, not an open-market purchase or sale of UNCY shares.

How many Unicycive (UNCY) RSUs vested immediately in Pramod Gupta’s award?

Of the 169,500 restricted stock units granted to Pramod Gupta, 23,542 shares vest upon grant. This immediate vesting portion is part of a larger RSU package that also includes a long-term monthly vesting schedule tied to ongoing service.

What is the vesting schedule for Pramod Gupta’s Unicycive (UNCY) RSU grant?

After 23,542 RSUs vest on grant, an additional 4,708 shares vest monthly over 31 months beginning June 1, 2026. All vesting is conditioned on Gupta’s continued service with Unicycive Therapeutics throughout the vesting period.

Is Pramod Gupta’s Unicycive (UNCY) RSU grant an open-market stock purchase?

No, the RSU grant is a compensation award, not an open-market purchase. The 169,500 restricted stock units are payable solely in common stock and were awarded at a stated price of $0.00 per unit as part of his executive compensation.

How many Unicycive (UNCY) shares are covered by Pramod Gupta’s RSU award after the transaction?

Following the transaction, Pramod Gupta’s reported position related to this RSU award covers 169,500 underlying shares of common stock. These shares will be delivered over time as the restricted stock units vest according to the stated schedule.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gupta Pramod

(Last)

(First)

(Middle)

C/O UNICYCIVE THERAPEUTICS, INC.

1975 W. EL CAMINO REAL, SUITE 204

(Street)

MOUNTAIN VIEW

CALIFORNIA

94040

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Unicycive Therapeutics, Inc. [ UNCY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, Pharmaceuticals and BD

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
05/20/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	$0	05/14/2026		A		169,500		⁽¹⁾	⁽¹⁾	Common Stock	169,500	$0	169,500	D

Explanation of Responses:

1. Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. 23,542 shares vest upon grant and 4,708 shares vest monthly over 31 months beginning June 1, 2026, subject to the Reporting Person's continued service with the Issuer.

	/s/ Pramod Gupta	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR